Publication | Closed Access

Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesPharmacologyCardiovascular PharmacologyCardiovascular ConsequencesIncretin—based TherapiesPharmacotherapyDiabetes ComplicationsDiabetes MellitusMedicinePotential Promise